Jilgyungyi
Glucose, Sodium Chloride
Jilgyungyi Co.,ltd.
Human Otc Drug
NDC 73004-010Jilgyungyi also known as Glucose, Sodium Chloride is a human otc drug labeled by 'Jilgyungyi Co.,ltd.'. National Drug Code (NDC) number for Jilgyungyi is 73004-010. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Jilgyungyi drug includes Anhydrous Dextrose - 305.82 mg/600mg Sodium Chloride - 213 mg/600mg . The currest status of Jilgyungyi drug is Active.
Drug Information:
| Drug NDC: | 73004-010 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Jilgyungyi |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Glucose, Sodium Chloride |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Jilgyungyi Co.,ltd. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Tablet |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | ANHYDROUS DEXTROSE - 305.82 mg/600mg
SODIUM CHLORIDE - 213 mg/600mg
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | VAGINAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 Mar, 2019 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 06 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | JILGYUNGYI CO.,LTD.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | 5SL0G7R0OK
451W47IQ8X
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 73004-010-02 | 6 BLISTER PACK in 1 CARTON (73004-010-02) / 600 mg in 1 BLISTER PACK (73004-010-01) | 01 Mar, 2019 | N/A | No |
| 73004-010-03 | 10 BLISTER PACK in 1 CARTON (73004-010-03) / 600 mg in 1 BLISTER PACK (73004-010-01) | 01 Mar, 2019 | N/A | No |
| 73004-010-04 | 20 BLISTER PACK in 1 CARTON (73004-010-04) / 600 mg in 1 BLISTER PACK (73004-010-01) | 01 Mar, 2019 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose purpose: odor care, prevent vaginitis
Product Elements:
Jilgyungyi glucose, sodium chloride anhydrous dextrose anhydrous dextrose sodium chloride chloride ion butylene glycol water allantoin
Indications and Usage:
Indications & usage uses: moisturizes vaginal dryness and helps to improve elasticity relieves external itching and alleviates odors before and after the menstruation
Warnings:
Warnings warnings: for vaginal use only do not use if you have (are) - an allergic reaction (rashes, and pimples, redness, swelling, skin irritation, discomfort, burning, vaginal peeling or bleeding, pain in the abdomen or pelvic area, fluttering heartbeat and chest pain, lumbar pain, abnormal vaginal secretion, pollakisuria, abnormal dryness, excessive menstrual bleeding, odor and green colored vaginal secretion, hypotension, faint, and papulopustule, pelvic pain) - pregnant - hyper sensitive skin and skin ailment - scars on vagina - itching, rash, swelling, redness, discomfort, burning, irritation vaginal peeling or bleeding when using this product - do not use while having the monthly menstrual period - prior to absorption there is a risk the tablet may fall out of the vagina - often wash towels or underwear and do not wear reuse underwear again prior to washing due to risk of infections - try to avoid sexual relations when you have vaginal yeast infection, it can be aggravated - tr
Read more...y not to use tampons and feminine cleansers - avoid contact with eye area - do not eat or swallow - do not use rubber products such as latex, condoms, and diaphragms together - do not use other vaginal tablets while using jil gyung yi if pregnant or breast-feeding, do not use. store at cool temperature and dry place with a closed container. avoid direct sunlight overdose warning - if you accidentally take the tablet orally, stop using this medication and see doctor immediately. stop use and ask a doctor if you have - fever (over 38°c), pain in abdomen, odor, lumbar pain, abnormal secretion, nausea and abnormal shoulder pain.
Dosage and Administration:
Dosage & administration directions: for adults â 2 tablets at the same time - for a first-timer, keep use 2 days consecutively and after that, use once a week. - do not use up to 6 hours prior to any sexual relation. - do not use up to 6 months after giving birth. - symptoms may vary depending on the age of the patient. directions - use only adults and children 12 years age and over 1) wash hands before using this product 2) open the package and vaginal tablets are placed into the vagina in much the same way as a tampon stand, squat, or lie on your back in a comfortable position then insert the tablets into the vagina as far as it will comfortably go. 3) it is recommended to use the treatment during night time prior to bed. 4) use of a sanitary pad after application, because there may be vaginal secretion 30min after application. if there are lots of secretion, change a new sanitary pad. 5) wash the area around the vagina (the vulva) gently next day, bacteria in your vaginal secre
Read more...tion can cause itching.
Package Label Principal Display Panel:
Package label.principal display panel - jilgyungyi 6 tablets image of carton
Package label.principal display panel - jilgyungyi 10 tablets image of carton
Package label.principal display panel - jilgyungyi 20 tablets image of carton